CAD 0.34
(1.49%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 6.65 Million CAD | 490.22% |
2022 | 1.11 Million CAD | -60.61% |
2021 | 2.83 Million CAD | 596.71% |
2020 | -570.11 Thousand CAD | -718.74% |
2019 | 92.14 Thousand CAD | 268.34% |
2018 | -54.73 Thousand CAD | -305.3% |
2017 | 26.66 Thousand CAD | 0.0% |
2016 | - CAD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 3.05 Million CAD | 44.83% |
2024 Q2 | 2.69 Million CAD | -5.57% |
2023 Q4 | 2.1 Million CAD | -26.39% |
2023 FY | 6.58 Million CAD | 490.22% |
2023 Q3 | 2.86 Million CAD | 92.42% |
2023 Q2 | 1.48 Million CAD | 153.08% |
2023 Q1 | 587.95 Thousand CAD | 130.55% |
2022 Q1 | 1.8 Million CAD | 6.67% |
2022 FY | 1.11 Million CAD | -60.61% |
2022 Q4 | -1.92 Million CAD | -465.5% |
2022 Q3 | 526.57 Thousand CAD | -26.14% |
2022 Q2 | 712.91 Thousand CAD | -60.4% |
2021 Q2 | 232.99 Thousand CAD | -42.29% |
2021 FY | 2.83 Million CAD | 596.71% |
2021 Q1 | 403.72 Thousand CAD | 132.22% |
2021 Q4 | 1.68 Million CAD | 232.81% |
2021 Q3 | 507.17 Thousand CAD | 117.68% |
2020 Q3 | -1.31 Million CAD | -2339.21% |
2020 Q2 | -53.74 Thousand CAD | -102.62% |
2020 FY | -570.11 Thousand CAD | -718.74% |
2020 Q1 | 2.04 Million CAD | 614.9% |
2020 Q4 | -1.25 Million CAD | 4.43% |
2019 Q4 | -397.65 Thousand CAD | -196.68% |
2019 Q3 | -134.03 Thousand CAD | 69.6% |
2019 FY | 92.14 Thousand CAD | 268.34% |
2019 Q2 | -440.93 Thousand CAD | -1935.46% |
2019 Q1 | 24.02 Thousand CAD | -0.49% |
2018 Q2 | 25.15 Thousand CAD | -24.92% |
2018 FY | -54.73 Thousand CAD | -305.3% |
2018 Q4 | 24.14 Thousand CAD | -31.35% |
2018 Q3 | 35.16 Thousand CAD | 39.79% |
2018 Q1 | 33.5 Thousand CAD | 71.28% |
2017 Q4 | 19.56 Thousand CAD | 175.61% |
2017 FY | 26.66 Thousand CAD | 0.0% |
2017 Q3 | 7098.00 CAD | 0.0% |
2016 FY | - CAD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Aurora Cannabis Inc. | 131.46 Million CAD | 94.935% |
Avant Brands Inc. | 12.43 Million CAD | 46.439% |
Cardiol Therapeutics Inc. | -248.35 Thousand CAD | 2781.119% |
Crescita Therapeutics Inc. | 10.36 Million CAD | 35.752% |
Knight Therapeutics Inc. | 152.65 Million CAD | 95.638% |
MediPharm Labs Corp. | 5.85 Million CAD | -13.727% |
OrganiGram Holdings Inc. | 35.07 Million CAD | 81.015% |
Canopy Growth Corporation | 80.88 Million CAD | 91.767% |
Willow Biosciences Inc. | -659 Thousand CAD | 1110.424% |
Auxly Cannabis Group Inc. | 21.27 Million CAD | 68.705% |